To find out the co-relation between Nodule formation after Botox and Covid-19 vaccination.

This case series examines the rare phenomenon of nodular formation following botulinum toxin injections, focusing on patient demographics, clinical presentations, and treatment approaches. The study includes diverse cases from various geographic regions to illustrate the complexity and variability in patient responses and outcomes. Following the COVID-19 pandemic and vaccination, there has been an increase in various adverse effects (AEs) and serious adverse effects (SAEs), including blood clotting and elevated stroke rates among vaccinated individuals. The first case involves a woman in her mid-40s, a frequent Botox user with a history of back and muscle pain, who contracted COVID-19 shortly before her injection. Post-injection, she developed painful nodules on her forehead and neck, initially treated with oral and intravenous steroids, antibiotics, and antihistamines. While she experienced some early improvement, noncompliance led to further complications, requiring additional interventions like massage and heat application. Ultimately, after sustained steroid therapy and surgical drainage, the nodules resolved. The second case focuses on a mid-50s woman with hypertension and hypothyroidism who also developed similar nodules after botulinum toxin injections but did not seek follow-up care. After receiving treatment from another physician involving steroids and antibiotics, she recovered after more than a year. This paper highlights a recurring pattern of nodular issues post-COVID-19 across various regions. Treatment approaches varied, including intralesional injections, steroids, and other topical and systemic therapies, with resolution times ranging from one week to several months. The findings underscore the importance of patient compliance and thorough pre-procedure discussions. Factors such as COVID-19 history, saline dilution types, and injection techniques may contribute to nodular formation. The study calls for further research to establish standardized management practices and address the underlying causes of these rare but significant complications. Here’s a rephrased version of your introduction, streamlined for clarity and conciseness: